Delivery Order SPE2DB24D9113-SPE2DB25FEQAT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will deliver the contraceptive devices to support federal healthcare needs. This delivery order was issued without a set-aside designation and is scheduled for completion by September 3, 2025. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $3,552.00, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg contraceptive systems to support the medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for ultimate completion on September 29, 2025, and represents a continuation of the company's ongoing pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group, a woman-owned small business based in Park Ridge, Illinois, will perform the work at its primary location. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and was awarded on September 12, 2025. No set-aside designation was applied to this...
- The Defense Logistics Agency issued a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, awarded on July 17, 2025, represents a standalone purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The order will be fulfilled from the contractor's facility in Park Ridge, Illinois, with an ultimate...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,619.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a completion date of September 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's single-award, indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems, with an ultimate completion date of October 6, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Mirena 52 mg contraceptive systems. The award was issued under a firm fixed-price contract with an ultimate completion date of September 4, 2025. This delivery order represents a discrete procurement from DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, which is valued at approximately $500 million and valid through November...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- SPE2DB24D9113Indefinite Delivery Contract
- SPE2DB24D9113-SPE2DB25FEQATDelivery Order
The Defense Logistics Agency issued a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. The award, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected to fulfill this requirement through its existing Indefinite Delivery Contract with the DLA. This delivery order is issued under DMS Pharmaceutical Group's substantial single-award IDC with the Defense Logistics Agency valued at $500 million and valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military health facilities worldwide. As a registered federal contractor since 2001, DMS Pharmaceutical Group has established itself as a critical supplier within the Defense Department's pharmaceutical supply chain, with a demonstrated portfolio of delivering specialty medications, biologics, and medical consumables to government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 6/2/25 |